Sunday, March 16, 2014

10 Best Sliver Stocks To Invest In Right Now

With Anchorman: The Legend Continues, Will Ferrell has bet that fans of the original Anchorman: the Legend of Ron Burgundy will turn out in droves for a sequel (a bet he looks to be winning). Likewise, investors bet big this week that the stock market’s rally would continue into 2014, despite the Federal Reserve’s decision to scale back its bond buying. Will this gamble work out as well?

The Standard & Poor’s 500 gained 2.4% this week to 1,818.31–a new record high–while the Dow Jones Industrial Average rose 3% to 16,221.14–also an all-time high.

Textron (TXT) rose 19% to $37.29 this week after it agreed to buy Beechcraft for $1.4 billion. Allergan (AGN) advanced 12% to $107.73 after Restatis was protected from generic competition, and�Vertex Pharmaceuticals�(VRTX) finished up� 10% at $71.83 after a clinical study didn’t show what the biotech company had hoped it would but left open the possibility of future success. 3M (MMM) jumped 8.1% to $136.72 after increasing its dividend, share buyback and guidance–and it was upgraded by JPMorgan to boot.

10 Best Sliver Stocks To Invest In Right Now: NTT DOCOMO Inc(DCM)

NTT DOCOMO, Inc. provides wireless telecommunications services, packet communications services, and satellite mobile communications services in Japan. It offers wireless voice and data communication services, such as second generation (2G) and third generation (3G) cellular services, and mobile multimedia services. The company provides mova services, on the 2G network, compatible with voice and data communication; FOMA services, on its 3G network, with voice and high-speed data communication, which are compatible with various services, such as videophone and video content downloading; and i-mode services, which are wireless Internet access services. As of March 31, 2010, it had approximately 56.08 million cellular subscribers. NTT DOCOMO also offers packet communications services, such as wireless data communications services using packet switching; satellite mobile communication services for communications in case of emergencies; and international calling and internationa l roaming services. In addition, the company provides mopera U Internet connection services for data cards and smartphones; embedded modules for automobile fleet management, wireless credit card settlement systems, and telemetric systems for automatic inventory checks between vending machines and service centers; and MyArea services that offer high-speed packet communication services for homes. Further, it offers home shopping services through TV media, high-speed Internet connection services for hotel facilities, advertisement services, and credit services, as well as develops, sells, and maintains IT systems. The company was formerly known as NTT Mobile Communications Network, Inc. and changed its name to NTT DOCOMO, Inc. in April 2000. NTT DOCOMO was founded in 1991 and is based in Tokyo, Japan. NTT DOCOMO, Inc. operates as a subsidiary of Nippon Telegraph and Telephone Corporation.

Advisors' Opinion:
  • [By Evan Niu, CFA]

    That's not to say that Apple doesn't have opportunities there, but rather that the country isn't at the top of its priority list. Apple has never inked a deal with Japan's largest wireless carrier, NTT DoCoMo (NYSE: DCM  ) , either. The top carrier currently has 61.6 million subscribers. Japan is actually one of the few countries where iOS has Android beat in market share. Kantar Worldpanel Comtech's first-quarter estimates peg iOS at 49.2%, with Android at 45.8%.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Japanese wireless carrier NTT DoCoMo (NYSE: DCM  ) has earned a coveted five-star ranking.

  • [By Evan Niu, CFA]

    Japan's top carrier NTT DoCoMo (NYSE: DCM  ) has never offered Apple's (NASDAQ: AAPL  ) iPhone, and that's not about to change anytime soon. NTT DoCoMo exec Kazuto Tsubouchi recently compared the device to DisneyLand, using the theme park as a comparison for a walled garden. The carrier would prefer to have more control over the experience, something that Apple isn't willing to give up.

10 Best Sliver Stocks To Invest In Right Now: Silver Wheaton Corp(SLW)

Silver Wheaton Corp., together with its subsidiaries, operates as a silver streaming company worldwide. The company has 14 long-term silver purchase agreements and 2 long-term precious metal purchase agreements whereby it acquires silver and gold production from the counterparties located in Mexico, the United States, Canada, Greece, Sweden, Peru, Chile, Argentina, and Portugal. Silver Wheaton Corp. is headquartered in Vancouver, Canada.

Advisors' Opinion:
  • [By Dan Caplinger]

    In the following video, Fool contributor Dan Caplinger explains the basics of the silver streaming business model that Silver Wheaton (NYSE: SLW  ) uses to contract with partner mining companies.

  • [By Doug Ehrman]

    Despite the weakness seen in precious metals a few weeks ago, silver has been relatively stable ever since mid-April, with the iShares Silver Trust (NYSEMKT: SLV  ) trading in a dollar-wide range ever since. With the presidents of the Chicago and Philadelphia Federal Reserve banks��releasing conflicting statements, turmoil may be just around the corner. Miners like Pan American (NASDAQ: PAAS  ) and First Majestic (NYSE: AG  ) are still facing operating challenges, while silver streaming darling Silver Wheaton (NYSE: SLW  ) struggles as well.

  • [By Travis Hoium]

    What: Gold and silver miners are taking it on the chin today. Royal Gold (NASDAQ: RGLD  ) fell as much as 10.4%, Allied Nevada Gold (NYSEMKT: ANV  ) fell up to 11.5%, and Silver Wheaton (NYSE: SLW  ) dropped as much as 11.2%.

  • [By Dan Caplinger]

    Yet there could be another shoe to drop. Across the industry, companies that have tied their dividends to prevailing bullion prices or financial results have had to pull back on their payouts. For instance, Silver Wheaton (NYSE: SLW  ) reduced its second-quarter dividend from $0.14 per share to $0.12, and the drop would have been larger if the company hadn't changed its calculation method to smooth changes in operating cash flow by looking back over four quarters. Hecla Mining (NYSE: HL  ) cut its dividend by 80% in May, and with silver prices having fallen further, the dividend could potentially disappear in the future. Newmont reduced its dividend by 18% in the first quarter, reversing its most recent increase the previous quarter. But with gold another 20% lower, further cuts could be imminent.

Hot Performing Stocks For 2014: KKR(KKR)

Kohlberg Kravis Roberts & Co. is a private equity and venture capital firm specializing in acquisitions, leveraged buyouts, management buyouts, and mezzanine investments in large cap companies. The firm will consider investments in all industries globally, with a focus on financial services, infrastructure, and renewable energy. It seeks a board seat in its portfolio companies. The firm holds a controlling interest in its portfolio companies after they go public. It typically holds its investment for a period of five years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. Kohlberg Kravis Roberts & Co. was founded in 1976 and is based at New York, New York with additional offices across United States, Europe, Australia, and Asia.

Advisors' Opinion:
  • [By Rich Duprey]

    Global investment firm KKR� (NYSE: KKR  ) is acquiring global contract research organization PRA International from San Francisco-based private equity firm�Genstar Capital for an undisclosed sum, PRA announced today. The New York Times reports that a "person briefed on the matter" said the price was about $1.3 billion.

  • [By Tim Brugger]

    After six years as CEO and managing director of�KKR's� (NYSE: KKR  ) �Japan operations, Shusaku Minoda has been named the division's new executive chairman, the company�announced Tuesday. Succeeding Minoda as CEO and managing director of KKR Japan is Hirofumi Hirano. The appointments become effective April 15.

  • [By Reuters]

    Itsuo Inouye/APA Panasonic 150-inch high-definition plasma TV on display at a 2008 expo in Tokyo. TOKYO -- Panasonic will pull out of the plasma television panel business by the end of the financial year to March 2014, sources familiar with the situation told Reuters, marking a key milestone in the long-term decline of Japan's TV industry. Panasonic had been widely expected to back out of the unprofitable business, but the exit comes sooner than predicted and underlines President Kazuhiro Tsuga's determination to weed out weak operations as he focuses on higher-margin products to end years of losses at the consumer electronics conglomerate. Panasonic's TV division has been a major contributor to the electronics company's combined $15 billion (9 billion pounds) net loss in its two latest financial years. Its TV business posted an operating loss of 88.5 billion yen ($913 million) in the last financial year. With the closure of its sole plasma panel factory in western Japan, Panasonic will book an impairment loss of more than 40 billion yen on the last remaining factory building in operation, the sources added. The company set aside 120 billion yen to cover restructuring costs at the start of the current financial year. The move also signals the demise in Japan of a technology in which TV makers once invested heavily but has now been overtaken by advances in the liquid crystal display business. Plasma display TVs accounted for less than 6 percent of global shipments in 2012, compared with 87 percent for LCD TVs, according to research firm DisplaySearch. Squeezed by the strong yen in recent years, Japan's TV makers have also lost their innovative edge against nimbler rivals such as South Korea's Samsung Electronics, with deep resources to spend on research and development. Sony (SNE), Panasonic and Sharp combined had a less than 20 percent share of the worldwide flat panel TV market by revenue. Samsung had a 27.7 percent share, and LG Electronics had 15 pe

10 Best Sliver Stocks To Invest In Right Now: Conmed Corp (CNMD)

CONMED Corporation (CONMED), incorporated on February 10, 1970, is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.

Arthroscopy

The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's arthroscopy products include powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants as well as related disposable products and fluid management systems. The Company also offers a line of video Endoscopy products suitable for uses in multi-specialty clinical environments beyond orthopedic arthroscopy, including laparoscopy, ear, nose and throat (ENT), gynecology and urology, as well as integrated operating room systems and equipment.

Powered Surgical Instruments

Electric, battery or pneumatic powered surgical instruments are used to perform orthopedic, arthroscopic and other surgical procedures where cutting, drilling or reaming of bone is required. Each power system consists of one or more handpieces and related accessories as well as disposable and limited reusable items (e.g., burs, saw blades, drills and reamers). Powered instruments are categorized as either small bone, large bone or specialty powered instruments. Specialty powered instruments are utilized in procedures such as spinal surgery, neurosurgery, ENT, oral/maxillofacial surgery, and cardiothoracic surgery.

The Company's line of powered instruments is sold principally under the Hall Surgical brand name, for use in large and small bone orthopedic, arthroscopic, oral/maxillofaci! al, podiatric, plastic, ENT, neurological, spinal and cardiothoracic surgeries. Large bone, neurosurgical, spinal and cardiothoracic powered instruments are sold primarily to hospitals while small bone arthroscopic, otolaryngological and oral/maxillofacial powered instruments are sold to hospitals, outpatient facilities and physicians offices.

The Company's powered instruments product line includes the MPower battery system. This orthopedic power system is specifically designed to meet the requirements of orthopedic applications. The MPower battery system allows a facility to purchase a single power system to perform total joint arthroplasty, trauma, arthroscopy, and small bone procedures. The system also provides a multitude of battery technologies to meet the varying needs of hospitals worldwide.

Electrosurgery

The use of electrosurgical units and associated surgical tools is commonplace in the hospital surgical suite, surgery centers, clinics and physician offices. Electrosurgery is routinely used to cut and coagulate tissue and small vessels in open and laparoscopic procedures using energy produced through radio frequency (RF) technology. Electrosurgery can be used in almost all surgical procedures including specialties, such as general, gynecology, orthopedics, cardiology, thoracics, urology, neurology, and dermatology. The Company�� portfolio consist of energy-based products is the Argon Beam Coagulation (ABC) technology. ABC technology combines the use of argon gas and electrosurgical energy to allow the surgeon to produce a surface coagulation which results in less tissue damage.

Patient Care

The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs. The Company also offers a line of suction instruments and tubing for use in the! operatin! g room, as well as a line of intravenous (IV) products for use in the critical care areas of the hospital.

Endosurgery

Endosurgery (also referred to as minimally invasive surgery or laparoscopic surgery) is surgery performed without a incision. The Company's Endosurgical products include the Reflex and PermaClip clip appliers for vessel and duct ligation, Universal S/I (suction/irrigation) and Universal Plus laparoscopic instruments and specialized suction/irrigation electrosurgical instrument systems for use in laparoscopic surgery. The Company also offers cutting and dilating trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles and linear cutters and staplers for use in laparoscopic surgery. The Company's disposable skin staplers are used to close large skin incisions with surgical staples, thus eliminating the time consuming suturing process. CONMED Endosurgery also offers a uterine manipulator called VCARE for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

Endoscopic Technologies

The Company offers a line of minimally invasive diagnostic and therapeutic products used in conjunction with procedures, which requires flexible endoscopy. The Company's principal customers include gastrointestinal (GI) endoscopists, pulmonologists, and nurses who perform both diagnostic and therapeutic endoscopic procedures in hospitals and outpatient clinics.

The Company's primary focus is to identify, develop, acquire, manufacture and market differentiated medical devices, which improve outcomes in the diagnosis and treatment of gastrointestinal and pulmonary disorders. The Company's diagnostic and therapeutic product offerings for GI and pulmonology include mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and ! polypecto! my.

The Company competes with Smith & Nephew, plc, Arthrex, Inc., Stryker Corporation, ArthroCare Corporation, Johnson & Johnson: DePuy Mitek, Inc., Biomet, Inc., Medtronic, Inc. Midas Rex and Xomed, Synvasive Technology, Inc., Synthes, Inc., MicroAire Surgical Instruments, LLC, Zimmer Holdings, Inc., Covidien Ltd.; Valleylab, Medline Industries, Inc., ERBE Elektromedizin GmbH, Megadyne, Kendall, 3M Company, Ethicon Endo-Surgery, Inc, U.S.Surgical, Boston Scientific Corporation, Wilson-Cook Medical, Inc, Olympus America, Inc. and STERIS Corporation.

Advisors' Opinion:
  • [By Seth Jayson]

    Margins matter. The more CONMED (Nasdaq: CNMD  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong CONMED's competitive position could be.

10 Best Sliver Stocks To Invest In Right Now: Sinovac Biotech Ltd.(SVA)

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. It offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination of hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the influenza A H1N1 virus. The company's pipeline vaccine candidates include a split viron vaccine, which completed Phase II clinical trials for the H5N1 influenza virus; and a SARS vaccine, which completed Phase I clinical trials for the SARS virus. In addition, its pipeline vaccine candidates that completed the pre-clinical trials comprise human vaccines for EV71, pneumococcal conjugate, haemophilus influenzae type b, meningitis, Japanese encephalitis, chickenpox, mumps, and rubella diseases, as well as rabies vaccine for humans and animals. The company markets and sell s its vaccine products directly to the provincial and municipal disease control and prevention centers. It has a patent license agreement with the National Institutes of Health; distribution agreements with LG Life Sciences, Ltd. and Glovax C.V.; and a pandemic influenza vaccine co-development agreement with the China Center for Disease Control and Prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.

Advisors' Opinion:
  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Sinovac Biotech (NASDAQ: SVA  ) has received the dreaded one-star ranking.

  • [By Rich Duprey]

    Troubling is that it's a new presence in humans, and while that makes its spread among the populace difficult, scientists fear that it's gaining momentum. Sinovac Biotech (NASDAQ: SVA  ) , which was approved to produce vaccines several years ago, jumped almost 7% yesterday as it gears up to mass produce a vaccine to combat the new threat.

10 Best Sliver Stocks To Invest In Right Now: Cleveland BioLabs Inc.(CBLI)

Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultan eously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.

Advisors' Opinion:
  • [By Lisa Levin]

    Cleveland BioLabs (NASDAQ: CBLI) plummeted 32.65% to $0.7610 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.

10 Best Sliver Stocks To Invest In Right Now: US Tungsten Corp (USTU)

US Tungsten Corp., formerly Stealth Resources Inc., incorporated on January 10, 2007, is an exploration-stage company. As of October 5, 2012, the Company had begun investigating tungsten opportunities. In September 2013, US Tungsten Corporation completed the registration and acquisition of 64 mineral claims located in Beaverhead, Montana.

On August 21, 2012, the Company acquired an option to acquire a 100% interest in three mineral claims known as the Calvert Property, located in Calvert, Montana (the Property). As of October 5, 2012, the Company had no operating revenues.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap mining stocks US Tungsten Corp (OTCMKTS: USTU) and LKA Gold Inc (OTCMKTS: LKAI) along with biotech Entest BioMedical Inc (OTCMKTS: ENTB) have been getting some attention lately in various investment newsletters with at least one of these stocks being the subject of paid promotions while another could soon be the subject of an investor relations campaign. But will any of these small cap stocks be winners for investors or traders? Here is a quick reality check:

10 Best Sliver Stocks To Invest In Right Now: Rising India Inc (RSII)

Rising India, Inc., incorporated on April 29, 1998, is a holding company. The Company is engaged in the developing independent living, assisted living and memory center communities. In May of 2013 Rising India, Inc. has acquired ownership of Mayer Luce Corp.

Rising India has researched acquisition and land-banking opportunities throughout Southern California based on new home developers like: D.R. Horton, Lennar, Ryland Homes, Standard Pacific and many others left fully entitled, development projects and planned communities vacant, unsold and basically guarded by private security services. These projects are in demand due to the Baby Boomers.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap stocks Rising India Inc (OTCMKTS: RSII), Innocap, Inc (OTCBB: INNO) and Amplitech Group Inc (OTCBB: AMPG) have all been the subject of recent paid for promotions or investor relation campaigns. And while there is nothing wrong with properly disclosed promotions, investors who aren�� traders and are looking for a long term investment need to be careful. With that said, do these three small caps have what it takes to succeed for the long haul? Here is a quick reality check before you jump in:

10 Best Sliver Stocks To Invest In Right Now: BioFuel Energy Corp.(BIOF)

BioFuel Energy Corp. produces and sells ethanol and its co-products in the United States. The company offers dried and wet distillers grains with solubles, corn oil, and carbon dioxide. It operates 2 ethanol production facilities located in Wood River, Nebraska and Fairmont, Minnesota with a combined production capacity of approximately 220 million gallons per year. The company sells its products to independent third party marketers and distributors. The company was founded in 2006 and is headquartered in Denver, Colorado.

Advisors' Opinion:
  • [By Roberto Pedone]

    BioFuel Energy (BIOF) is engaged in the production and sale of ethanol and its co-products through its two ethanol production facilities located in Nebraska and Minnesota. This stock closed up 9.4% to $4.04 in Tuesday's trading session.

    Tuesday's Range: $3.69-$4.04

    52-Week Range: $2.70-$10.75

    Tuesday's Volume: 152,000

    Three-Month Average Volume: 57,949

    From a technical perspective, BIOF soared higher here back above its 50-day moving average of $3.76 with above-average volume. This move is quickly pushing shares of BIOF within range of triggering a major breakout trade. That trade will hit if BIOF manages to take out some near-term overhead resistance levels at $3.99 to $4.12 with high volume. At last check, BIOF hit an intraday high of $4.04 and volume was well above its three-month average action of 57,949 shares.

    Traders should now look for long-biased trades in BIOF as long as it's trending above its 50-day at $3.76 or above more near-term support at $3.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 57,949 shares. If that breakout hits soon, then BIOF will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $4.63 to $5.19. Any high-volume move above $5.19 will then put $5.50 to $6 within range for shares of BIOF.

10 Best Sliver Stocks To Invest In Right Now: TeleNav Inc.(TNAV)

TeleNav, Inc. provides personalized navigation and location based services (LBS) in the United States and internationally. It offers GPS Navigator, a voice guided, real time, turn by turn mobile navigation service on a white label basis, such as Sprint Navigation and AT&T Navigator, as well as under the TeleNav brand. The company also provides mobile resource management solutions that allow enterprises to monitor and manage mobile workforces and assets by using its LBS platform to track job status and the location of workers, field assets, and equipment. Its enterprise solutions include TeleNav Track service, as well as TeleNav Vehicle Manager, TeleNav Vehicle Tracker, and TeleNav Asset Tracker. In addition, the company offers mobile navigation services through on-board and connected systems. Further, it focuses on developing LBS to new device platforms, such as tablet devices, as well as new LBS for mobile phones, including location based mobile advertising, commerce, and social networking. The company distributes its services to consumers, wireless carriers, enterprises and automobile manufacturers, and original equipment manufacturers through its wireless carrier partners, as well as through its Web site and mobile phone application stores. TeleNav, Inc. is headquartered in Sunnyvale, California.

Advisors' Opinion:
  • [By Louis Navellier]

    Lately, FleetCor has been on a buying spree. This spring, FLT agreed to buy out Telenav’s (TNAV) mobile business — an operation that serves 8,000 business clients by tracking the location of mobile workers in field-based businesses. FleetCor aims to adopt the business to add value to its ongoing fuel card programs.

No comments:

Post a Comment